Created at	Source	Raw Value	Validated value
April 23, 2022, 1:30 a.m.	usa	Percent of Participants Showing a Severe Disease Progression Composite Outcome;Percent of Participants With Discontinuation of Therapy (for Any Reason);Percent of Participants With Grade 3 or 4 AEs Through Day 30;Percent of Participants With SAE Through Day 30	Percent of Participants Showing a Severe Disease Progression Composite Outcome;Percent of Participants With Discontinuation of Therapy (for Any Reason);Percent of Participants With Grade 3 or 4 AEs Through Day 30;Percent of Participants With SAE Through Day 30
Oct. 26, 2020, 11:31 p.m.	usa	Cumulative incidence of SAEs through day 30;Severe disease progression composite outcome;Incidence of discontinuation of therapy (for any reason);Cumulative incidence of grade 3 or 4 AEs through day 30	Cumulative incidence of SAEs through day 30;Severe disease progression composite outcome;Incidence of discontinuation of therapy (for any reason);Cumulative incidence of grade 3 or 4 AEs through day 30